ARCHIVES

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

This article is from The Cancer Letter archive.

Vol. 11 No. 31 | August 2, 1985

Download PDF Visit The Full Archive

Related Articles

Health Organizations: ACS Statement Supports funding of Research On Human Stem cells

December 17, 1999

Combination Therapy Improves Survival For HIV+ Patients

February 24, 2006

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

NCI Advisors Approve Continuation Of Cancer Genome Atlas Network.

December 19, 2008

DCPC Concepts Approved

September 27, 1985

Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item

May 2, 1980